phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with nitroarginine in 2 studies
| Studies (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Trials (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Recent Studies (post-2010) (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Studies (nitroarginine) | Trials (nitroarginine) | Recent Studies (post-2010) (nitroarginine) |
|---|---|---|---|---|---|
| 276 | 0 | 55 | 3,935 | 11 | 175 |
| Protein | Taxonomy | phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide (IC50) | nitroarginine (IC50) |
|---|---|---|---|
| Nitric oxide synthase, endothelial | Bos taurus (cattle) | 1.2 | |
| Nitric oxide synthase, endothelial | Homo sapiens (human) | 0.38 | |
| Nitric oxide synthase, brain | Homo sapiens (human) | 1.265 | |
| Nitric oxide synthase, brain | Rattus norvegicus (Norway rat) | 4.12 | |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 0.5 | |
| Nitric oxide synthase, inducible | Homo sapiens (human) | 6.2 | |
| Nitric oxide synthase, brain | Mus musculus (house mouse) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Claunch, AE; Corbit, BP; Jones, JA; Kacher, D; Lake, JR; Malin, DH; Moon, WD; Morel, J; Smith, DA; Stevens, PA; Webb, SL | 1 |
| Chang, M; Chen, LX; Chen, Q; Fang, Q; Guo, J; Wang, R | 1 |
2 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and nitroarginine
| Article | Year |
|---|---|
Nitric oxide synthesis inhibition attenuates behavioral actions of neuropeptide FF.
Topics: Animals; Arginine; Cerebral Ventricles; Enzyme Inhibitors; Injections, Intraventricular; Male; Narcotic Antagonists; Nitric Oxide Synthase; Nitroarginine; Oligopeptides; Rats; Rats, Sprague-Dawley; Stereoisomerism; Stereotyped Behavior; Substance Withdrawal Syndrome | 1996 |
Neuropeptide FF receptors exert contractile activity via inhibition of nitric oxide release in the mouse distal colon.
Topics: Acetylcholine; Animals; Arginine; Biological Assay; Colon, Sigmoid; Enzyme Inhibitors; In Vitro Techniques; Mice; Muscle Contraction; Neuropeptides; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oligopeptides; Receptors, Neuropeptide | 2005 |